Viewing Study NCT01613950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-02-06 @ 12:38 AM
Study NCT ID: NCT01613950
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2012-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA … View